SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-100638
Filing Date
2023-09-14
Accepted
2023-09-14 09:00:15
Documents
16
Period of Report
2023-09-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2324696d5_8k.htm   iXBRL 8-K 36892
2 EXHIBIT 1.1 tm2324696d5_ex1-1.htm EX-1.1 229261
3 EXHIBIT 4.2 tm2324696d5_ex4-2.htm EX-4.2 188771
4 EXHIBIT 5.1 tm2324696d5_ex5-1.htm EX-5.1 9204
8 GRAPHIC tm2324696d5_ex1-1img001.jpg GRAPHIC 3530
  Complete submission text file 0001104659-23-100638.txt   729721

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA gild-20230914.xsd EX-101.SCH 3009
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE gild-20230914_lab.xml EX-101.LAB 34240
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gild-20230914_pre.xml EX-101.PRE 22355
10 EXTRACTED XBRL INSTANCE DOCUMENT tm2324696d5_8k_htm.xml XML 3209
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES, INC. (Filer) CIK: 0000882095 (see all company filings)

IRS No.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19731 | Film No.: 231254130
SIC: 2836 Biological Products, (No Diagnostic Substances)